Bioinputs market expected to grow more than 20% in Brazil in 2025

Date:03-06-2025

The bioinputs sector in Brazil continues to expand and may achieve growth exceeding 20% in 2025, with projected revenue expected to surpass R$9 billion by 2030. The data was presented by the National Association for Promotion and Innovation of the Biological Industry (ANPII Bio) during the 2nd ANPII Bio Market Intelligence Workshop.

According to Anderson Ribeiro, founding partner of 5P2R consulting and speaker at the event, the Brazilian bioinputs sector is primarily driven by biofungicides, bionematicides, and bioinsecticides, which together represent more than 80% of the biodefensive market.

"Today, the biological segment in Brazil has a very interesting characteristic: there is no single company that dominates the market. We explore the biology existing in soil and plants, select efficient microorganisms, multiply them on an industrial scale, and make them available to producers. Besides being sustainable, it's a very democratic technology," states Ribeiro.

The survey presented by ANPII Bio indicates that the Brazilian biological inputs sector already covers an area of 156 million hectares, generating R$5.7 billion in revenue in the last season. The data, collected from 23 associated companies, reveals sales growth of 4.9% in inoculants and 12.6% in biological pesticides, as well as increases of 12.4% and 29.1% in trading volume, respectively.

By the end of the decade, projections suggest the bioinputs sector will expand by 60%, with industry companies advancing 12.4% annually in inoculant sales and 20.4% in the biopesticide market. According to ANPII Bio, the major driver of this growth will be the increasing adoption of technologies such as nutrient-solubilizing inoculants and bioinsecticides.

However, Anderson Ribeiro emphasizes that despite accelerated growth, the sector still faces challenges. One of these is the need for greater technical knowledge among producers and regulation for new products. According to the specialist, with investments in research, development, and training, biologicals should establish themselves as protagonists in agriculture of the future.

Larissa Simon, operations director of ANPII Bio, states that the recent approval of the Bioinputs Law, enacted in 2024, should further boost this growth by establishing a regulatory framework for the production and commercialization of biological inputs in the country. "The new legislation should reduce bureaucracy and create incentives for research and development of multifunctional products," she said.

Brazil represents 11.3% of the global bioinputs market, positioning itself as one of the largest consumers in this category. In specific segments, such as bioinoculants and biopesticides, Brazilian representation is higher, reaching 12.6%, with projections to reach 16.4% by the end of the decade.

The 2nd ANPII Bio Market Intelligence Workshop brought together business leaders and industry experts. Among the topics addressed were the impact of the recently approved new legislation for the sector, agricultural financing, and trends for the bioinputs market, highlighting the accelerated growth and accessibility of these solutions for producers of different sizes.

(Editing by Leonardo Gottems, reporter for AgroPages)